Global Malignant Pleural Mesothelioma (MPM) Pipeline Insights Report 2020: MTG201, YS110, Poly-ICLC (Hiltonol) Vaccine, rAd-IFN, Nivolumab and ipilimumab, ONCOS-102 - ResearchAndMarkets.com